Safety of Ayurvedic Metal Origin Bhasma (Dhatu varga) through Acute Toxicity Studies: A Review

Authors

  • Pravin Jawanjal PhD scholar, Dept. of Rasashastra and Bhaishajya Kalpana, IPGT&RA, Gujarat Ayurved University, Jamnagar, Gujarat, India
  • Prashant Bedarkar Associate Professor, Dept. of Rasashastra and Bhaishajya Kalpana, IPGT&RA, Gujarat Ayurved University, Jamnagar, Gujarat, India
  • Biswajit Patgiri Professor and HOD Dept. of Rasashastra and Bhaishajya Kalpana, IPGT&RA, Gujarat Ayurved University, Jamnagar, Gujarat, India
  • S.S. Savrikar Scientific Advisory Board Member, CCRAS Vice-Chancellor (Ex)- Gujarat Ayurved University, Professor and Head, Department of Rasa Shastra, RA Podar Ayurvedic Medical College, Worli Mumbai, India

DOI:

https://doi.org/10.37591/rrjot.v9i3.1697

Abstract

Bhasma possess broad-spectrum therapeutic utility but are blamed due to frequently raising toxicity concerns. Although their safety has been evident with practice since ancient times, scientifically proven through toxicity studies, clinical safety, still comprehensive conclusive documentation is needed. Online published research articles on in vivo, oral single dose, acute toxicity studies on Bhasma of Dhatu Varga were searched through search engines and observations on behavioural, ponderal, autopsy, maximum tolerated dose (MTD), LD50 and safety were summarized. Total 11 published paper of acute toxicity study of Dhatu Bhasma (Rajata Bhasma (RB)-1, Tamra Bhasma (TB)-3, Vanga Bhasma (VB)-3, Naga Bhasma (NB)-1, Yashada Bhasma (YB)-1, Loha Bhasma (LB)-1, Trivanga Bhasma-1 were found in rat (Wistar Albino-2, Charles Foster albino-1, Albino-1 total-4) and mice (Swiss Albino-1, Albino-1 total-3) models, MTD and LD50 of RB are 1500 and >2000 mg/kg, three out of eighteen mice died on day 11. LD50 of LB and NB is >4160 mg/kg, with honey and also > than 40 and 100 time of TED, respectively. TB (Kajjali (black sulphide of mercury), Gandhaka marit-Shuddha, (purification) Ashuddha, with and without Amritikarana) has LD50 >2000 mg/kg licked with honey and it is > 40 TED in Hingula, Gandhaka Marita TB. YB (30 Kukkuta Puta (calcination) up to 300 mg/kg (100 times TED) and YB (Parada pishti, Gandhaka Marit) > 40 TED) is safer. Vastraputi VB up to the 2000 mg/kg (40 TED) and VB (Parada Pishti, Hartala and Jarit Vanaspati Marit by 3, 4 and 7 Puta (calcination), respectively) at 400 mg/kg are safe. Bhasma of Rajat, Loha, Tamra, Yashada, Naga and Vanga are safe at behavioural and some at ponderal, autopsy level through per oral single dose, in vivo acute toxicity studies in rat and mice at 2000, 4160, 2000, 300, 4160 and 2000 mg/kg body weight of animals which are up to 100 times of TED.

 

Keyword: Safety, Ayurveda, Bhasma, acute toxicities, maximum tolerated dose (MTD), clinical safety

 

Cite this Article

Pravin Jawanjal, Prashant Bedarkar, Biswajit Patgiri, S.S. Savrikar. Safety of Ayurvedic Metal Origin Bhasma (Dhatu varga) through Acute Toxicity Studies: A Review. Research & Reviews: A Journal of Toxicology. 2019; 9(3): 43–50p.

Downloads

Published

2019-12-27

Issue

Vol. 9 No. 3 (2019)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.